Company Filing History:
2 out of 1,197 
1 out of 5,307 
Years Active: 2013-2016
Title: Chia-Rung Lu: Innovator in Gene Modulation and Polyglutamine Diseases
Introduction
Chia-Rung Lu is an accomplished inventor based in Taipei, Taiwan, recognized for his significant contributions to the field of genetics and biotechnology. With two patents to his name, Lu has focused his research on developing innovative methods for modulating gene expression, particularly in relation to polyglutamine diseases.
Latest Patents
Lu's latest patents revolve around advanced methods for modulating the expression and aggregation of CAG-expanded gene products within cells. His inventions aim to tackle the critical challenge of polyglutamine-mediated protein aggregation, which is linked to various neurological disorders, including Huntington's disease. The methodologies he has developed involve the manipulation of genes containing more than 36 CAG trinucleotide repeats. Specifically, by reducing the expression of the SPT4 gene or the SUPT4H gene, or by inhibiting the formation of Spt4/Spt5 complexes or Supt4h/Supt5h complexes, Lu has paved the way for identifying agents that could effectively modulate these gene products. His work offers promising avenues for treating polyglutamine diseases, positioning him as a notable figure in this crucial area of research.
Career Highlights
Chia-Rung Lu has made impactful strides in the academic and research community. He has been affiliated with prestigious institutions, including National Yang-Ming University and Leland Stanford Junior University. Through his work, he has established himself as a valuable contributor to the ongoing dialogue in genetics and polymer science.
Collaborations
Throughout his career, Lu has collaborated with talented individuals in the field, including his coworkers Tzu-Hao Cheng and Tzu-Han Wang. These collaborations underscore the value of teamwork in driving innovation and advancing research in genetic modulation.
Conclusion
Chia-Rung Lu's innovative spirit and dedication to addressing complex genetic issues through his patents have set a solid foundation for future advancements in treating polyglutamine-related diseases. His research not only contributes to scientific understanding but also holds potential for developing effective therapies for individuals affected by these challenging conditions.